Day 3 Program

Clinical Controversies: Management of the Axilla in Multidisciplinary Care

Day 3: December 11, 2025

1:00 PM–2:15 PM CST

Stars at Night 1-2

Session Details

This session will explore strategies for de-escalating axillary surgery and regional nodal radiation after neoadjuvant chemotherapy in clinically node-positive patients, and how these approaches will influence adjuvant therapy decisions in HR+/HER2- breast cancer.

Moderator

Tari A. King, Emory University, Atlanta, GA

CT2-01

De-escalation of axillary surgery after NAC in clinically node positive patients

Giacomo Montagna, Memorial Sloan Kettering Cancer Center, New York, NY

CT2-02

De-escalation of regional nodal radiation after NAC in clinically node positive patients

Lori Pierce, University of Michigan, Ann Arbor, MI

CT2-03

Adjuvant therapy decisions in HR+HER2- breast cancer in the era of axillary de-escalation

Sherry Shen, Memorial Sloan Kettering Cancer Center, New York, NY

Advocate

N. Beth Emery, Alamo Breast Cancer Foundation, San Antonio, TX